SEC Comment Letter 0000000000-23-001410 to CalciMedica, Inc. (CALC)

CalciMedica, Inc.
Date: Feb. 10, 2023 · CIK: 0001534133 · Accession: 0000000000-23-001410

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 001-39538

Date

February 10, 2023

Author

Frederic Guerard

Form

UPLOAD

Company

CalciMedica, Inc.

Letter

United States securities and exchange commission logo February 10, 2023 Frederic Guerard, Pharm.D. President and Chief Executive Officer Graybug Vision, Inc. 203 Redwood Shores Parkway, Suite 620 Redwood City, CA 94065 Re:Graybug Vision, Inc. Preliminary Proxy Statement on Schedule 14A Filed December 14, 2022 File No. 001-39538 Dear Frederic Guerard: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Julia Forbess, Esq.

Show Raw Text

United States securities and exchange commission logo
February 10, 2023
Frederic Guerard, Pharm.D.
President and Chief Executive Officer
Graybug Vision, Inc.
203 Redwood Shores Parkway, Suite 620
Redwood City, CA 94065
Re:Graybug Vision, Inc.
Preliminary Proxy Statement on Schedule 14A
Filed December 14, 2022
File No. 001-39538
Dear Frederic Guerard:
            We have completed our review of your filing.  We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:       Julia Forbess, Esq.

SecProbe.io